Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DnaJ heat shock protein family (Hsp40) member B5 (DNAJB5) is a molecular chaperone and co-chaperone belonging to the Hsp40 (DnaJ) family, characterized by an N-terminal DNAJ domain and a C-terminal substrate-binding domain, though lacking the cysteine-rich domain seen in some other family members[3][7][8]. It is primarily involved in recognizing and binding to unfolded proteins, facilitating correct protein refolding and cellular protein quality control, thereby protecting cells from protein misfolding stress[1][2][3][7][8]. The protein is typically upregulated during cell stress, such as heat shock, and acts in concert with Hsp70 chaperones[1][8]. In mouse models, its interaction in multi-protein complexes can contribute to the regulation of cardiac hypertrophy[3]. DNAJB5 is not currently recognized as a direct therapeutic target or drug receptor, and no drugs or clinical biomarkers are specifically listed for it[3][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DnaJ heat shock protein family (Hsp40) member B5 (DNAJB5).